Basic information Description Biological activity Uses Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Antipyretic analgesics >  Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) >  Tapinarof

Tapinarof

Basic information Description Biological activity Uses Safety Supplier Related

Tapinarof Basic information

Product Name:
Tapinarof
Synonyms:
  • 3,5-Dihydroxy-4-isopropylstilbene
  • (E)-2-(1-Methylethyl)-5-(2-phenylethenyl)-1,3-benzenediol
  • 2-(1-methylethyl)-5-[(E)-2-phenylethenyl]benzene-1,3-diol
  • 3,5-Dihydroxy-4-isopropyl-trans-stilbene
  • GSK2894512)
  • Tapinarof (WBI 1001
  • Tapinarof
  • WB-1001
CAS:
79338-84-4
MF:
C17H18O2
MW:
254.32
EINECS:
1312995-182-4
Mol File:
79338-84-4.mol
More
Less

Tapinarof Chemical Properties

Melting point:
140 - 142°C
Boiling point:
431.8±20.0 °C(Predicted)
Density 
1.158
storage temp. 
2-8°C
solubility 
Chloroform (Slightly), Methanol (Slightly)
pka
9.86±0.15(Predicted)
form 
Solid
color 
Pale Brown to Light Brown
More
Less

Tapinarof Usage And Synthesis

Description

Tapinarof is a small molecule stilbene compound, with a chemical name of 3,5-Dihydroxy-4-isopropylstilbene,which was originally isolated from the metabolite of photorhabdus iuminescence, a soil nematode (Heterorhabditis sp.), and has been synthesized artificially.

Biological activity

Tapinarof(GSK2894512) is a natural agonist of aryl hydrocarbon receptor (AhR) that induces nuclear translocation of AhR in immortalized keratinocytes (HaCaT) with EC50 of 0.16 nM. Benvitimod induces apoptosis in CD4+ T cells in a dose-dependent manner with an IC50 value of 5.2 μM.

Uses

Clinically, tapinarof was first used in the treatment of psoriasis and atopic dermatitis. Clinical trials conducted abroad have shown that Benzenemod cream has good efficacy and safety on atopic dermatitis and psoriasis. In China, as a class 1.1 new drug, Benzenemod cream has undergone phase I-II clinical trials, and the results show that it has good efficacy and safety for plaque psoriasis.

Clinical Use

Tapinarof is a novel small molecule topical therapeutic AhR ( aryl hydrocarbon receptor)-modulating agent that has been recently approved by the FDA for the topical treatment of plaque psoriasis in adults. Tapinarof 1% cream has shown to be effective and to have a favorable safety profile in the treatment of psoriatic patients[1]. It could decrease the expression of multiple essential cytokines involved in the pathological IL-23/IL-17/IL-22 axis and ameliorate IMQ-induced psoriatic dermatitis, inhibiting keratinocyte proliferation and abnormal differentiation. But tapinarof may have different effects on varied types of psoriasis[2]. Tapinarof can also specifically bind to and activate AHR leading to downregulation of TNF-α/IL-23/IL-17 and inhibition of IL-4/IL-13 mediated STAT6 activation, to achieve the purpose of treating nonulcerated necrobiosis lipoidica[3].

in vivo

Tapinarof acts through AhR to reduce inflammation in IMQ-treated mice. AhR-sufficient mice on a C57Bl/6 background exhibit a reduced clinical score after treatment with Tapinarof or 6-formylindolo(3,2-b)carbazole (FICZ). In contrast, AhR KO mice do not respond to the anti-inflammatory effects of Tapinarof. FICZ is used as a comparator in these studies and yields similar results, with dramatically reduced inflammatory responses in wild-type, but not AhR KO mice.

References

[1] Bissonnette R, et al. Tapinarof for psoriasis and atopic dermatitis: 15?years of clinical research. Journal of the European Academy of Dermatology and Venereology, 2023; 37: 1168-1174.
[2] Zhu X, et al. The opposite effect of tapinarof between IMQ and IL-23 induced psoriasis mouse models. Experimental Dermatology, 2023.
[3] Palomares S, et al. Nonulcerated Necrobiosis Lipoidica Successfully Treated with Tapinarof: A Case Report. Clinical, Cosmetic and Investigational Dermatology, 2023; 16: 1373-1376.

TapinarofSupplier

Hangzhou LinghepharmTechnology Co.,Ltd. Gold
Tel
+86-18571465433 18571465433
Email
sales@linghepharm.com
Wuhan HSN Pharmaresearch CO., LTD. Gold
Tel
027-63499089 18086100502
Email
linwell@126.com
Hubei wei shi reagent group ltd., company Gold
Tel
027-59105166 13125137732
Email
2853863890@qq.com
Suzhou Biosyntech Co., Ltd. Gold
Tel
0512-63001269 15720870325
Email
sales2@biosyntech-suzhou.com
Hubei Innerse Biotechnology Co., Ltd. Gold
Tel
027-027-88189299 18186187538
Email
sales@innersebio.com